Dutch Journal of Oncology (NTvO)

The Dutch Journal of Oncology (NTvO) is a journal for clinical training of medical specialists in the field of oncology, including internal medicine specialists such as, medical oncologists, gynaecologists, urologists,pulmonologists, haematologists, gastrointestinal specialists, neurologists and other internal medicine specialists working in oncology, as well as radiotherapists, oncological surgeons and hospital pharmacists with focus area oncology. The journal is published 8 times a year and is distributed through controlled circulation free of charge to all practicing medical specialists in oncology in the Netherlands. NTVO is also the official communication platform of SONCOS, the Society of all medical specialists clinically active in Oncology in the Netherlands. In addition, NTVO is the official scientific journal of the Dutch Society of Radiotherapists (NVRO).

NTvO is a practical and informative medical journal. The aim of the journal is to provide insight and overview of the latest medical developments. Through NTvO, one is informed quickly about new relevant developments for clinical practice in the field of oncology. The content is compiled by an independent editorial board, is written by doctors working in the filed of oncology, oncological surgery or radiotherapy and is peer-reviewed in order to warrant objective information.

Of course, NTvO is open to contributions from readers. Spontaneous submissions can be published after review and approval by the editorial board. More information about submissions is available under: Submission of manuscripts.

Editorial Board

CHIEF EDITOR

Mw. dr. H.W. Kapiteijn, internist-oncoloog, LUMC, Leiden

 

EDITORIAL BOARD

Dhr. dr. A.C.J. van Akkooi, melanoom- en sarcoomchirurg, AVL, Amsterdam
Mw. dr. A. Becker-Commissaris, longarts, Amsterdam UMC, locatie VUmc, Amsterdam
Mw. dr. A.M. van Berkel, maag-darm-leverarts, Medisch Centrum Alkmaar, Alkmaar
Dhr. prof. dr. R. de Bree, KNO arts/hoofd-halschirurg, UMCU Cancer Center, Utrecht
Dhr. dr. M.P.G. Broen, neuro-oncoloog, MUMC+, Maastricht
Dhr. dr. T. Dijkema, radiotherapeut-oncoloog, Radboudumc, Nijmegen
Mw. dr. A.-M.C. Dingemans, longarts, MUMC+, Maastricht

Mw. dr. N. Haj Mohammad, medisch oncoloog, UMCU, Utrecht
Mw. dr. L. Hol, maag-darm-leverarts, Erasmus MC, Rotterdam
Dhr. dr. M.P.W. Intven, radiotherapeut, UMCU, Utrecht
Mw. dr. M. Kok, medisch oncoloog, AVL, Amsterdam
Mw. dr. S.K. Krisnadath, maag-darm-leverarts, Amsterdam UMC, locatie AMC, Amsterdam
Dhr. prof. dr. L. Massuger, gynaecoloog, Radboudumc, Nijmegen
Mw. dr. E. van Meerten, internist oncoloog, Erasmus MC Kanker Instituut, Rotterdam
Dhr. dr. N. Mehra, internist-oncoloog, Radboudumc, Nijmegen
Dhr. prof. dr. R.J.A. van Moorselaar, uroloog, Amsterdam UMC, lokatie VUmc, Amsterdam
Dhr. prof. dr. C. Rosman, gastro-intestinaal oncologisch chirurg, Radboudumc, Nijmegen
Dhr. dr. F.M.N.H. Schramel, longarts, St. Antonius Ziekenhuis, Nieuwegein
Dhr. dr. J.J. Swen, ziekenhuisapotheker, LUMC, Leiden
Dhr. prof. dr. M. Verheij, radiotherapeut, AVL, Amsterdam
Mw. dr. M. Vos, neuroloog, MCH – Medisch Centrum Haaglanden, locatie Westeinde, Den Haag
dhr. dr. S.M. Willems, patholoog, UMCU, Utrecht
Dhr. dr. C.M. Zwaan, assoc. prof. pediatrische oncologie, hoofd afdeling kinderoncologie/hematologie, Erasmus MC, Sophia Kinderziekenhuis, Rotterdam

Submission of manuscripts

Author Instructions


These author instructions provide a detailed overview of the requirements for the different article types of the journal.

Patient consent


If your manuscript contains photo’s, scans or videos of patients, please print and return this form of written consent to us after it has been signed by both the patient and yourself as author of the manuscript.

Copyright


All authors of an article need to sign the copyright form.

Contact


Do you have questions, remarks or do you like to receive more information?
Please contact us.

Deze website gebruikt cookies voor de juiste werking en om de bezoeker de beste gebruikservaring te geven. Wij gebruiken geen cookies om u te volgen voor marketing doeleinden. Klik op de 'Accepteer' knop om hiermee in te stemmen.